首页> 外文期刊>Ultrastructural pathology >Ultrastructural characterization of genetic diffuse lung diseases in infants and children: A cohort study and review
【24h】

Ultrastructural characterization of genetic diffuse lung diseases in infants and children: A cohort study and review

机译:婴幼儿遗传性弥漫性肺疾病的超微结构表征:一项队列研究和综述

获取原文
获取原文并翻译 | 示例
       

摘要

Pediatric diffuse lung diseases are rare disorders with an onset in the neonatal period or in infancy, characterized by chronic respiratory symptoms and diffuse interstitial changes on imaging studies. Genetic disorders of surfactant homeostasis represent the main etiology. Surfactant protein B and ABCA3 deficiencies typically cause neonatal respiratory failure, which is often lethal within a few weeks or months. Although heterozygous ABCA3 mutation carriers are mostly asymptomatic, there is growing evidence that monoallelic mutations may affect surfactant homeostasis. Surfactant protein C mutations are dominant or sporadic disorders leading to a broad spectrum of manifestations from neonatal respiratory distress syndrome to adult pulmonary fibrosis. The authors performed pathology and ultrastructural studies in 12 infants who underwent clinical lung biopsy. One carried a heterozygous SP-B mutation, 3 carried SP-C mutations, and 7 carried ABCA3 mutations (5 biallelic and 2 monoallelic). Optical microscopy made it possible to distinguish between surfactant-related disorders and other forms. One of the ABCA3 monoallelic carriers had morphological features of alveolar capillary dysplasia, a genetic disorder of lung alveolar, and vascular development. One patient showed no surfactant-related anomalies but had pulmonary interstitial glycogenosis, a developmental disorder of unknown origin. Electron microscopy revealed specific lamellar bodies anomalies in all SP-B, SP-C, and ABCA3 deficiency cases. In addition, the authors showed that heterozygous ABCA3 mutation carriers have an intermediate ultrastructural phenotype between homozygous carriers and normal subjects. Lung biopsy is an essential diagnostic procedure in unexplained diffuse lung disorders, and electron microscopy should be performed systematically, since it may reveal specific alterations in genetic disorders of surfactant homeostasis.
机译:小儿弥漫性肺部疾病是罕见的疾病,在新生儿期或婴儿期发病,其特征是慢性呼吸道症状和影像学检查发现弥漫性间质改变。表面活性剂稳态的遗传障碍是主要病因。表面活性蛋白B和ABCA3缺乏症通常会导致新生儿呼吸衰竭,这通常在几周或几个月内致命。尽管杂合的ABCA3突变携带者大多无症状,但越来越多的证据表明单等位基因突变可能会影响表面活性剂的体内稳态。表面活性蛋白C突变是显性或偶发性疾病,导致从新生儿呼吸窘迫综合征到成人肺纤维化的广泛表现。作者对12例行临床肺活检的婴儿进行了病理学和超微结构研究。一个携带杂合子SP-B突变,三个携带SP-C突变,七个携带ABCA3突变(5个双等位基因和2个单等位基因)。光学显微镜使区分表面活性剂相关疾病和其他形式成为可能。一种ABCA3单等位基因携带者具有肺泡毛细血管发育不良,肺泡遗传性疾病和血管发育的形态特征。一名患者未表现出与表面活性剂相关的异常,但患有肺间质糖原异生病,原因不明。电子显微镜检查显示在所有SP-B,SP-C和ABCA3缺乏症病例中都有特定的层状体异常。此外,作者表明,杂合ABCA3突变携带者在纯合携带者和正常人之间具有中等超微结构表型。肺活检是无法解释的弥漫性肺部疾病的重要诊断程序,应系统地进行电子显微镜检查,因为它可能揭示表面活性剂稳态的遗传疾病的特定改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号